DOI:
10.1055/s-00043197
Journal of Gastrointestinal and Abdominal Radiology
LinksClose Window
References
Eisenberg BL, Harris J, Blanke CD. et al.
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
J Surg Oncol 2009;
99 (01) 42-47
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.